#

Novo Nordisk

: 101
Sales of Wegovy in tablets beat forecasts / Photo: JHVEPhoto / Shutterstock
News·
Sales of Novo Nordisk's obesity pill double expectations. Shares soared
AI solutions provider for collecting and analyzing large sets of disparate data (Big Data) Palantir is poised to surpass Nvidia in long-term sales growth / Photo: rblfmr/Shutterstock.com
News·
US employment, Palantir and Novo earnings: what investors need to know this week
Elon Musk is pushing the idea of accelerating SpaceXs inclusion in the S&P 500 after its IPO, which is set to be the largest in history / Photo: Alessia Pierdomenico/Shutterstock.com
News·
S&P goes after SpaceX, Uzbekistan fund to offer discount: the main thing about the IPO by Ma. 3
Hemab is developing therapies for blood coagulation disorders such as Glanzmann thrombasthenia and Von Willebrand Disease, according to its filings / Photo: Hemab Therapeutics
Small Caps·
+1
·
Hemab IPO: Novo-backed blood disorder biotech debuts on the Nasdaq
Boston-based biotech Avalyn Pharma develops inhaled drugs / Photo: Avalyn Pharma
News·
Avalyn Pharma IPO: Novo Nordisk-backed biotech goes public
Novo Nordisk intends to implement OpenAI AI tools in all business processes by the end of 2026 / Photo: Below the Sky/Shutterstock.com
News·
"Superpower Charge": Novo Nordisk bets on OpenAI in confrontation with Eli Lilly
SpaceX plans to reserve a record high percentage of shares for retail investors at its IPO / Photo: Wirestock Creators/Shutterstock.com
News·
SpaceX, OpenAI and the London listing of Uzbekistan's national fund: highlights of the IPO by April 12
Forecasts for the expected size of the global market for obesity treatments have dropped about 30% to $100 billion by 2030, Noble Capital Markets writes / Photo: Shutterstock.com
Small Caps·
The obesity therapy market is changing. What smid-cap investors should know.
Pharmaceutical giant Eli Lilly sagged 1.1% in trading on March 17. Photo: Jonathan Weiss/Shutterstock
News·
Eli Lilly received a rare "sell" recommendation from analysts. Shares fell by 6%
Shares of online pharma platform operator Hims & Hers were adding about 47% on the premarket on March 9 / Photo: Photo Nature Travel / Shutterstock
News·
Shares of online pharmacy Hims & Hers soared 40% amid a general sell-off. What is it?
According to three investment banks Eli Lilly could emerge as the leader in the weight loss drug race / Photo: Tada Image / Shutterstock.com
News·
Three investment banks named Eli Lilly as the leader in the weight loss drug race
Nvidia will release quarterly results after the close of trading on February 25 / Photo: Nor Gal / Shutterstock.com
News·
Morning in New York: Nvidia will set the bidding vector
Load more